<img width="235" height="200" alt="2013FDAEnforcementNewsPromo235px" src="/site/files/oldnewsfiles/2013FDAEnforcementNewsPromo235px.jpg" class="FloatRight">Hot topics in U.S. food and drug law, including off-label prescription drug use and criminal sanctions, and pharmacy compounding, will frame the discussion at an upcoming event on Widener Law’s Delaware campus.<br><br>The program, presented by the school’s <a href="/CampusLife/ActivitiesandOrganizations/OtherDelawareOrganizations/FDLA.aspx">Food and Drug Law Association</a> will take place Wednesday, March 20 from noon to 2 p.m. in the Ruby R. Vale Moot Courtroom at 4601 Concord Pike. A light reception will follow the event.<br><br>The program will address issues related to enforcement of the U.S. Food, Drug and Cosmetic Act such as “off-label” First Amendment issues,  criminal sanctions. ethical matters and more.<br><br>Speakers include:
<ul>
<li>
<a href="/Academics/Faculty/ProfilesHbgAdj/TerminiRoseannB.aspx">Roseann B. Termini</a>, Widener Law adjunct professor of food and drug law.</li>
<li>Karyn M. Campbell, director of the Food &amp; Drug Administration investigation branch for the Philadelphia district.</li>
<li>Albert S. Glenn, an assistant U.S. attorney for the Eastern District of Pennsylvania.</li>
</ul>
Attorneys from Delaware and Pennsylvania who attend the program will be eligible for two continuing legal education credits, including one ethics credit. New Jersey attorneys may self report with a Widener Law certificate of attendance. The registration fee for attorneys who attend for credit is $40 and includes the post-event reception. Attendance is free for students or members of the public not seeking continuing legal education credits. <br><br>To register, contact Carol Perrupato at 302.477.2178 or <a href="mailto:caperrupato@widener.edu">caperrupato@widener.edu</a>.